Contact this trialFirst, we need to learn more about you.
Epigenetic Modifier
Tazemetostat + CAR T Therapy for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1
New York, New York
This trial is testing if combining a pill with CAR T cell therapy can improve ability to kill lymphoma cells without safety issues in DLBCL, FL, and MCL. Participants will be followed up to 5 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.